Duchenne Muscular Dystrophy: Current understanding and treatment

Preview Video

Course Content

Expand All
Duchenne muscular dystrophy is the most common, terminal, childhood, genetic illness and at the same time is likely the most misunderstood condition. Recent innovative research has uncovered many mysteries of Duchenne including its etiology, pathophysiology and treatment. It is vital that we have a thorough understanding of the disease and deliver appropriate treatments based on the current evidence. Inadequate understanding of the disease can lead to muscle injury of patients who are already at risk for severe muscle degeneration. This course will explain the incidence, etiology, pathophysiology, progression and the stages of mobility of Duchenne. Therapy treatment, orthopedic management, activity modification and equipment selection will be covered. An update on current research and clinical trials. This course is ideal for PT, PTA, OT, COTA, SLP, PE/APE, RN and others involved in the care of persons with Duchenne.
$75.00 USD

About the Instructor

Jennifer Wallace

Jennifer Wallace

Jennifer Wallace, PT, draws from experience in pediatrics since 2002 and with an emphasis in the muscular dystrophy population. She has been invited to present current treatment topics and advances at Duchenne conferences, Academy of Pediatric PT and has taught continuing education to healthcare professionals since 2009. She is the owner of Duchenne Therapy Network, a private PT business and Professional Development Director at CureDuchenne, a non-profit patient outreach and education program. She continues to practice and provides evaluation, treatment and consultations for those with Duchenne and Becker muscular dystrophy.